HEAD AND NECK CANCER TREATMENT IN INDIA
Tìm thấy 10,000 tài liệu liên quan tới từ khóa "HEAD AND NECK CANCER TREATMENT IN INDIA":
CHAPTER 084 HEAD AND NECK CANCER PART 5
Chapter 084. Head and Neck Cancer (Part 5) Head and Neck Cancer: Treatment Patients with head and neck cancer can be categorized into three clinical groups: those with localized disease, those with locally or[r]
5 Đọc thêm
PERIOPERATIVE CHANGES IN OSTEOPONTIN AND TGFΒ1 PLASMA LEVELS AND THEIR PROGNOSTIC IMPACT FOR RADIOTHERAPY IN HEAD AND NECK CANCER
In head and neck cancer little is known about the kinetics of osteopontin (OPN) expression after tumor resection. In this study we evaluated the time course of OPN plasma levels before and after surgery.
8 Đọc thêm
CETUXIMAB-INDUCED ASEPTIC MENINGITIS: CASE REPORT AND REVIEW OF A RARE ADVERSE EVENT
Cetuximab is a commonly used antibody agent in the treatment of colorectal or head and neck cancer. Although it is generally well tolerated in most patients, cetuximab has been associated with some rare but serious adverse events. Aseptic meningitis is one such distinctly uncommon adverse drug react[r]
CHAPTER 084 HEAD AND NECK CANCER PART 2
endoscopy or biopsy; these patients are considered to have carcinoma of unknown primary (Fig. 84-1). If the enlarged nodes are located in the upper neck and the tumor cells are of squamous cell histology, the malignancy probably arose from a mucosal surface in the head[r]
5 Đọc thêm
CHAPTER 084 HEAD AND NECK CANCER PART 4
Chapter 084. Head and Neck Cancer (Part 4) Table 84-2 Definition of TNM–Nasopharynx Primary Tumor (T) Stage Grouping TX Cannot be assessed Stage 0 Tis N0 M0 T0 No evidence Stage I T1 N0 M0 Tis Carcinoma in situ Stage IIA T2a N0 M0
5 Đọc thêm
CHAPTER 084. HEAD AND NECK CANCER (PART 6) PPT
Chapter 084. Head and Neck Cancer (Part 6) Chemoprevention β-Carotene and cis-retinoic acid can lead to the regression of leukoplakia. However, cis-retinoic acid does not reduce the incidence of second primaries Treatment Complications Complications from
5 Đọc thêm
Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma
The gene encoding fibroblast growth factor receptor 1 (FGFR1) is emerging as a therapeutic and prognostic biomarker in various cancer types, including head and neck squamous cell carcinoma (SCC).
TREATMENT STRATEGY AND OUTCOMES IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: A NATIONWIDE RETROSPECTIVE COHORT STUDY (KCSG HN13–01)
By investigating treatment patterns and outcomes in locally advanced head and neck squamous cell carcinoma (LA-HNSCC), we aimed at providing valuable insights into the optimal therapeutic strategy for physicians in real-world practice.
9 Đọc thêm
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
We investigated whether head and neck squamous cell carcinoma (HNSCC) patient-derived xenografts (PDXs) reaffirm patient responses to anti-cancer therapeutics.
CHAPTER 081. PRINCIPLES OF CANCER TREATMENT (PART 6) PPSX
radiation fields, and individual susceptibility. Bone is among the most radioresistant organs, radiation effects being manifested mainly in children through premature fusion of the epiphyseal growth plate. By contrast, the male testis, female ovary, and bone marrow are the most[r]
5 Đọc thêm
FEASIBILITY AND ACCEPTABILITY OF COMBINING COGNITIVE BEHAVIOURAL THERAPY TECHNIQUES WITH SWALLOWING THERAPY IN HEAD AND NECK CANCER DYSPHAGIA
Head and neck cancer squamous cell carcinoma (HNSSC) patients report substantial rates of clinically significant depression and/or anxiety, with dysphagia being a predictor of distress and poorer quality of life. Evidence-based dysphagia interventions largely focus on the remediation of physical imp[r]
NEW PASTE FOR SEVERE STOMATITIS IN PATIENTS UNDERGOING HEAD-AND-NECK CANCER RADIOTHERAPY AND/OR CHEMOTHERAPY WITH ORAL APPLIANCE
The aim of the present study was to evaluate the physical properties of “admixture paste”, which is a commercially available gel containing hinokitiol for use against severe stomatitis, and its characteristics as a moisturizing gel and denture adhesive.
G-8 INDICATES OVERALL AND QUALITY-ADJUSTED SURVIVAL IN OLDER HEAD AND NECK CANCER PATIENTS TREATED WITH CURATIVE RADIOCHEMOTHERAPY
Evidence-based guidelines concerning the older head and neck cancer (HNCA) patient are lacking. Accurate patient selection for optimal care management is therefore challenging. We examined if geriatric assessment is indicative of long-term health-related quality of life (HRQOL) and overall survival[r]
EXPRESSION OF OCT3/4 AND NANOG IN THE HEAD AND NECK SQUAMOUS CARCINOMA CELLS AND ITS CLINICAL IMPLICATIONS FOR DELAYED NECK METASTASIS IN STAGE I/II ORAL TONGUE SQUAMOUS CELL CARCINOMA
The side population (SP) of cancer cells is reportedly enriched with cancer stem cells (CSCs), however, the functional role and clinical relevance of CSC marker molecules upregulated in the SP of head and neck squamous carcinoma (HNSCC) cells are yet to be elucidated.
14 Đọc thêm
AN EFFECTIVE AND WELL-TOLERATED STRATEGY IN RECURRENT AND/OR METASTATIC HEAD AND NECK CANCER: SUCCESSIVE LINES OF ACTIVE CHEMOTHERAPEUTIC AGENTS
The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatment, alternative therapies are often offered to patients.
Regular recreational physical activity and risk of head and neck cancer
Study subject recruitment
Data for the current analysis are from an ongoing HNC case – control study that began subject recruitment on September 1, 2010. Because questions on RPA were added later, the current analysis included subjects that were recruited from March 20, 2011 to October 29, 2015. S[r]
Data for the current analysis are from an ongoing HNC case – control study that began subject recruitment on September 1, 2010. Because questions on RPA were added later, the current analysis included subjects that were recruited from March 20, 2011 to October 29, 2015. S[r]
SUMMARY OF DOCTORAL THESIS IN MEDICINE: ANTICANCER EFFECTS OF VACCINE STRAIN MEASLES VIRUS IN COMBINATION WITH NIMOTUZUMAB IN TREATMENT OF LARYNGEAL CANCER IN VITRO AND IN VIVO
To evaluate the anticancer effect of measles vaccine virus in combination with Nimotuzumab in vitro. To evaluate the anticancer effect of measles vaccine virus in combination with Nimotuzumab on nude mouse model with head and neck cancer (in vivo).
30 Đọc thêm
SWALLOWING INTERVENTIONS FOR THE TREATMENT OF DYSPHAGIA AFTER HEAD AND NECK CANCER: A SYSTEMATIC REVIEW OF BEHAVIOURAL STRATEGIES USED TO PROMOTE PATIENT ADHERENCE TO SWALLOWING EXERCISES
Dysphagia is a significant side-effect following treatment for head and neck cancers, yet poor adherence to swallowing exercises is frequently reported in intervention studies. Behaviour change techniques (BCTs) can be used to improve adherence, but no review to date has described the techniques or[r]
CLINICAL OUTCOMES OF IMMUNE CHECKPOINT INHIBITORS FOR PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK CANCER: REALWORLD DATA IN KOREA
Anti-PD1 inhibitors have been approved for the treatment of recurrent or metastatic head and neck cancer (HNC), as a result of Global Phase III trials. However, the clinical outcomes of immune checkpoint inhibitors in patients who are not eligible for clinical trials or have various medical conditio[r]
9 Đọc thêm
EXPRESSION OF EIF5A2 ASSOCIATES WITH POOR SURVIVAL OF NASOPHARYNGEAL CARCINOMA PATIENTS TREATED WITH INDUCTION CHEMOTHERAPY
Nasopharyngeal carcinoma (NPC) is a type of head-neck cancer with a distinguishable geographic and racial distribution worldwide. Increasing evidence supports that the accumulation of additional genetic and epigenetic abnormalities is important in driving the NPC tumorigenic process.